189 related articles for article (PubMed ID: 33151394)
1. Glioblastoma post-operative imaging in neuro-oncology: current UK practice (GIN CUP study).
Booth TC; Luis A; Brazil L; Thompson G; Daniel RA; Shuaib H; Ashkan K; Pandey A
Eur Radiol; 2021 May; 31(5):2933-2943. PubMed ID: 33151394
[TBL] [Abstract][Full Text] [Related]
2. Imaging timing after glioblastoma surgery (INTERVAL-GB): protocol for a UK and Ireland, multicentre retrospective cohort study.
Gillespie CS; Bligh ER; Poon MTC; Solomou G; Islim AI; Mustafa MA; Rominiyi O; Williams ST; Kalra N; Mathew RK; Booth TC; Thompson G; Brennan PM; Jenkinson MD; ; ; ;
BMJ Open; 2022 Sep; 12(9):e063043. PubMed ID: 36100297
[TBL] [Abstract][Full Text] [Related]
3. Taming Glioblastoma in "Real Time": Integrating Multimodal Advanced Neuroimaging/AI Tools Towards Creating a Robust and Therapy Agnostic Model for Response Assessment in Neuro-Oncology.
de Godoy LL; Chawla S; Brem S; Mohan S
Clin Cancer Res; 2023 Jul; 29(14):2588-2592. PubMed ID: 37227179
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging: diagnosis and response assessment in glioblastoma.
Clarke JL; Chang SM
Cancer J; 2012; 18(1):26-31. PubMed ID: 22290254
[TBL] [Abstract][Full Text] [Related]
5. Neuro-oncology practices in Australia: a Cooperative Group for Neuro-Oncology patterns of care study.
Chen JY; Hovey E; Rosenthal M; Livingstone A; Simes J
Asia Pac J Clin Oncol; 2014 Jun; 10(2):162-7. PubMed ID: 23714694
[TBL] [Abstract][Full Text] [Related]
6. Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee.
Kiesel B; Thomé CM; Weiss T; Jakola AS; Darlix A; Pellerino A; Furtner J; Kerschbaumer J; Freyschlag CF; Wick W; Preusser M; Widhalm G; Berghoff AS
BMC Cancer; 2020 May; 20(1):410. PubMed ID: 32398144
[TBL] [Abstract][Full Text] [Related]
7. Anatomical and functional MR imaging to define tumoral boundaries and characterize lesions in neuro-oncology.
Benzakoun J; Robert C; Legrand L; Pallud J; Meder JF; Oppenheim C; Dhermain F; Edjlali M
Cancer Radiother; 2020 Aug; 24(5):453-462. PubMed ID: 32278653
[TBL] [Abstract][Full Text] [Related]
8. Shape Features of the Lesion Habitat to Differentiate Brain Tumor Progression from Pseudoprogression on Routine Multiparametric MRI: A Multisite Study.
Ismail M; Hill V; Statsevych V; Huang R; Prasanna P; Correa R; Singh G; Bera K; Beig N; Thawani R; Madabhushi A; Aahluwalia M; Tiwari P
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2187-2193. PubMed ID: 30385468
[TBL] [Abstract][Full Text] [Related]
9. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
[TBL] [Abstract][Full Text] [Related]
10. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
[TBL] [Abstract][Full Text] [Related]
11. Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.
Barajas RF; Hamilton BE; Schwartz D; McConnell HL; Pettersson DR; Horvath A; Szidonya L; Varallyay CG; Firkins J; Jaboin JJ; Kubicky CD; Raslan AM; Dogan A; Cetas JS; Ciporen J; Han SJ; Ambady P; Muldoon LL; Woltjer R; Rooney WD; Neuwelt EA
Neuro Oncol; 2019 Mar; 21(4):517-526. PubMed ID: 30277536
[TBL] [Abstract][Full Text] [Related]
12. Advanced magnetic resonance imaging in glioblastoma: a review.
Shukla G; Alexander GS; Bakas S; Nikam R; Talekar K; Palmer JD; Shi W
Chin Clin Oncol; 2017 Aug; 6(4):40. PubMed ID: 28841802
[TBL] [Abstract][Full Text] [Related]
13. Clinical Review of Computed Tomography and MR Perfusion Imaging in Neuro-Oncology.
Trinh A; Wintermark M; Iv M
Radiol Clin North Am; 2021 May; 59(3):323-334. PubMed ID: 33926680
[TBL] [Abstract][Full Text] [Related]
14. Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).
Hofer S; Keller K; Imbach L; Roelcke U; Hutter G; Hundsberger T; Hertler C; Le Rhun E; Vasella F; Cordier D; Neidert M; Hottinger A; Migliorini D; Pflugshaupt T; Eggenberger N; Baumert B; Läubli H; Gramatzki D; Reinert M; Pesce G; Schucht P; Frank I; Lehnick D; Weiss T; Wirsching HG; Wolpert F; Roth P; Weller M
Swiss Med Wkly; 2021 May; 151():w20501. PubMed ID: 34000060
[TBL] [Abstract][Full Text] [Related]
15. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
16. Disease Assessments in Patients with Glioblastoma.
Phillips KA; Kamson DO; Schiff D
Curr Oncol Rep; 2023 Sep; 25(9):1057-1069. PubMed ID: 37470973
[TBL] [Abstract][Full Text] [Related]
17. Preradiotherapy MR Imaging: A Prospective Pilot Study of the Usefulness of Performing an MR Examination Shortly before Radiation Therapy in Patients with Glioblastoma.
Majós C; Cos M; Castañer S; Pons A; Gil M; Fernández-Coello A; Macià M; Bruna J; Aguilera C
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2224-2230. PubMed ID: 27609621
[TBL] [Abstract][Full Text] [Related]
18. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract][Full Text] [Related]
19. Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.
McClelland S; Sosanya O; Mitin T; Degnin C; Chen Y; Attia A; Suh JH; Jaboin JJ
J Neurooncol; 2018 Oct; 140(1):155-158. PubMed ID: 29987746
[TBL] [Abstract][Full Text] [Related]
20. Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.
Merkel A; Soeldner D; Wendl C; Urkan D; Kuramatsu JB; Seliger C; Proescholdt M; Eyupoglu IY; Hau P; Uhl M
J Neurooncol; 2017 Apr; 132(2):249-254. PubMed ID: 28101701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
